Pediatric Medicines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Pediatric Medicines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Pediatric Medicines industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Pediatric Medicines 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pediatric Medicines worldwide and market share by regions, with company and product introduction, position in the Pediatric Medicines market
Market status and development trend of Pediatric Medicines by types and applications
Cost and profit status of Pediatric Medicines, and marketing status
Market growth drivers and challenges
The report segments the global Pediatric Medicines market as:
Global Pediatric Medicines Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Pediatric Medicines Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Pills
Granules
Capsules
Global Pediatric Medicines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Children's Hospital
Pharmacy
Global Pediatric Medicines Market: Manufacturers Segment Analysis (Company and Product introduction, Pediatric Medicines Sales Volume, Revenue, Price and Gross Margin):
GSK
Sanofi
Bristol-Myers Squibb
Abbott
Novartis
Pfizer
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Lupin Pharmaceuticals
Merck Sharp & Dohme
RedHill
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pediatric Medicines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Pediatric Medicines industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Pediatric Medicines 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pediatric Medicines worldwide and market share by regions, with company and product introduction, position in the Pediatric Medicines market
Market status and development trend of Pediatric Medicines by types and applications
Cost and profit status of Pediatric Medicines, and marketing status
Market growth drivers and challenges
The report segments the global Pediatric Medicines market as:
Global Pediatric Medicines Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Pediatric Medicines Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Pills
Granules
Capsules
Global Pediatric Medicines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Children's Hospital
Pharmacy
Global Pediatric Medicines Market: Manufacturers Segment Analysis (Company and Product introduction, Pediatric Medicines Sales Volume, Revenue, Price and Gross Margin):
GSK
Sanofi
Bristol-Myers Squibb
Abbott
Novartis
Pfizer
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Lupin Pharmaceuticals
Merck Sharp & Dohme
RedHill
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PEDIATRIC MEDICINES
1.1 Definition of Pediatric Medicines in This Report
1.2 Commercial Types of Pediatric Medicines
1.2.1 Pills
1.2.2 Granules
1.2.3 Capsules
1.3 Downstream Application of Pediatric Medicines
1.3.1 Hospital
1.3.2 Children's Hospital
1.3.3 Pharmacy
1.4 Development History of Pediatric Medicines
1.5 Market Status and Trend of Pediatric Medicines 2013-2023
1.5.1 Global Pediatric Medicines Market Status and Trend 2013-2023
1.5.2 Regional Pediatric Medicines Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pediatric Medicines 2013-2017
2.2 Sales Market of Pediatric Medicines by Regions
2.2.1 Sales Volume of Pediatric Medicines by Regions
2.2.2 Sales Value of Pediatric Medicines by Regions
2.3 Production Market of Pediatric Medicines by Regions
2.4 Global Market Forecast of Pediatric Medicines 2018-2023
2.4.1 Global Market Forecast of Pediatric Medicines 2018-2023
2.4.2 Market Forecast of Pediatric Medicines by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Pediatric Medicines by Types
3.2 Sales Value of Pediatric Medicines by Types
3.3 Market Forecast of Pediatric Medicines by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Pediatric Medicines by Downstream Industry
4.2 Global Market Forecast of Pediatric Medicines by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Pediatric Medicines Market Status by Countries
5.1.1 North America Pediatric Medicines Sales by Countries (2013-2017)
5.1.2 North America Pediatric Medicines Revenue by Countries (2013-2017)
5.1.3 United States Pediatric Medicines Market Status (2013-2017)
5.1.4 Canada Pediatric Medicines Market Status (2013-2017)
5.1.5 Mexico Pediatric Medicines Market Status (2013-2017)
5.2 North America Pediatric Medicines Market Status by Manufacturers
5.3 North America Pediatric Medicines Market Status by Type (2013-2017)
5.3.1 North America Pediatric Medicines Sales by Type (2013-2017)
5.3.2 North America Pediatric Medicines Revenue by Type (2013-2017)
5.4 North America Pediatric Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Pediatric Medicines Market Status by Countries
6.1.1 Europe Pediatric Medicines Sales by Countries (2013-2017)
6.1.2 Europe Pediatric Medicines Revenue by Countries (2013-2017)
6.1.3 Germany Pediatric Medicines Market Status (2013-2017)
6.1.4 UK Pediatric Medicines Market Status (2013-2017)
6.1.5 France Pediatric Medicines Market Status (2013-2017)
6.1.6 Italy Pediatric Medicines Market Status (2013-2017)
6.1.7 Russia Pediatric Medicines Market Status (2013-2017)
6.1.8 Spain Pediatric Medicines Market Status (2013-2017)
6.1.9 Benelux Pediatric Medicines Market Status (2013-2017)
6.2 Europe Pediatric Medicines Market Status by Manufacturers
6.3 Europe Pediatric Medicines Market Status by Type (2013-2017)
6.3.1 Europe Pediatric Medicines Sales by Type (2013-2017)
6.3.2 Europe Pediatric Medicines Revenue by Type (2013-2017)
6.4 Europe Pediatric Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Pediatric Medicines Market Status by Countries
7.1.1 Asia Pacific Pediatric Medicines Sales by Countries (2013-2017)
7.1.2 Asia Pacific Pediatric Medicines Revenue by Countries (2013-2017)
7.1.3 China Pediatric Medicines Market Status (2013-2017)
7.1.4 Japan Pediatric Medicines Market Status (2013-2017)
7.1.5 India Pediatric Medicines Market Status (2013-2017)
7.1.6 Southeast Asia Pediatric Medicines Market Status (2013-2017)
7.1.7 Australia Pediatric Medicines Market Status (2013-2017)
7.2 Asia Pacific Pediatric Medicines Market Status by Manufacturers
7.3 Asia Pacific Pediatric Medicines Market Status by Type (2013-2017)
7.3.1 Asia Pacific Pediatric Medicines Sales by Type (2013-2017)
7.3.2 Asia Pacific Pediatric Medicines Revenue by Type (2013-2017)
7.4 Asia Pacific Pediatric Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Pediatric Medicines Market Status by Countries
8.1.1 Latin America Pediatric Medicines Sales by Countries (2013-2017)
8.1.2 Latin America Pediatric Medicines Revenue by Countries (2013-2017)
8.1.3 Brazil Pediatric Medicines Market Status (2013-2017)
8.1.4 Argentina Pediatric Medicines Market Status (2013-2017)
8.1.5 Colombia Pediatric Medicines Market Status (2013-2017)
8.2 Latin America Pediatric Medicines Market Status by Manufacturers
8.3 Latin America Pediatric Medicines Market Status by Type (2013-2017)
8.3.1 Latin America Pediatric Medicines Sales by Type (2013-2017)
8.3.2 Latin America Pediatric Medicines Revenue by Type (2013-2017)
8.4 Latin America Pediatric Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Pediatric Medicines Market Status by Countries
9.1.1 Middle East and Africa Pediatric Medicines Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Pediatric Medicines Revenue by Countries (2013-2017)
9.1.3 Middle East Pediatric Medicines Market Status (2013-2017)
9.1.4 Africa Pediatric Medicines Market Status (2013-2017)
9.2 Middle East and Africa Pediatric Medicines Market Status by Manufacturers
9.3 Middle East and Africa Pediatric Medicines Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Pediatric Medicines Sales by Type (2013-2017)
9.3.2 Middle East and Africa Pediatric Medicines Revenue by Type (2013-2017)
9.4 Middle East and Africa Pediatric Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PEDIATRIC MEDICINES
10.1 Global Economy Situation and Trend Overview
10.2 Pediatric Medicines Downstream Industry Situation and Trend Overview
CHAPTER 11 PEDIATRIC MEDICINES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Pediatric Medicines by Major Manufacturers
11.2 Production Value of Pediatric Medicines by Major Manufacturers
11.3 Basic Information of Pediatric Medicines by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Pediatric Medicines Major Manufacturer
11.3.2 Employees and Revenue Level of Pediatric Medicines Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PEDIATRIC MEDICINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 GSK
12.1.1 Company profile
12.1.2 Representative Pediatric Medicines Product
12.1.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of GSK
12.2 Sanofi
12.2.1 Company profile
12.2.2 Representative Pediatric Medicines Product
12.2.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Sanofi
12.3 Bristol-Myers Squibb
12.3.1 Company profile
12.3.2 Representative Pediatric Medicines Product
12.3.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
12.4 Abbott
12.4.1 Company profile
12.4.2 Representative Pediatric Medicines Product
12.4.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Abbott
12.5 Novartis
12.5.1 Company profile
12.5.2 Representative Pediatric Medicines Product
12.5.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Novartis
12.6 Pfizer
12.6.1 Company profile
12.6.2 Representative Pediatric Medicines Product
12.6.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Pfizer
12.7 Cipla
12.7.1 Company profile
12.7.2 Representative Pediatric Medicines Product
12.7.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Cipla
12.8 Eisai Pharmaceuticals
12.8.1 Company profile
12.8.2 Representative Pediatric Medicines Product
12.8.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Eisai Pharmaceuticals
12.9 Eli Lilly
12.9.1 Company profile
12.9.2 Representative Pediatric Medicines Product
12.9.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Eli Lilly
12.10 F. Hoffman-La Roche
12.10.1 Company profile
12.10.2 Representative Pediatric Medicines Product
12.10.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of F. Hoffman-La Roche
12.11 Glenmark
12.11.1 Company profile
12.11.2 Representative Pediatric Medicines Product
12.11.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Glenmark
12.12 Helsinn Healthcare
12.12.1 Company profile
12.12.2 Representative Pediatric Medicines Product
12.12.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Helsinn Healthcare
12.13 Heron Therapeutics
12.13.1 Company profile
12.13.2 Representative Pediatric Medicines Product
12.13.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Heron Therapeutics
12.14 Ipca Laboratories
12.14.1 Company profile
12.14.2 Representative Pediatric Medicines Product
12.14.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Ipca Laboratories
12.15 Sun Pharmaceutical Industries
12.15.1 Company profile
12.15.2 Representative Pediatric Medicines Product
12.15.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
12.16 Takeda Pharmaceutical
12.17 Lupin Pharmaceuticals
12.18 Merck Sharp & Dohme
12.19 RedHill
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PEDIATRIC MEDICINES
13.1 Industry Chain of Pediatric Medicines
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PEDIATRIC MEDICINES
14.1 Cost Structure Analysis of Pediatric Medicines
14.2 Raw Materials Cost Analysis of Pediatric Medicines
14.3 Labor Cost Analysis of Pediatric Medicines
14.4 Manufacturing Expenses Analysis of Pediatric Medicines
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Pediatric Medicines in This Report
1.2 Commercial Types of Pediatric Medicines
1.2.1 Pills
1.2.2 Granules
1.2.3 Capsules
1.3 Downstream Application of Pediatric Medicines
1.3.1 Hospital
1.3.2 Children's Hospital
1.3.3 Pharmacy
1.4 Development History of Pediatric Medicines
1.5 Market Status and Trend of Pediatric Medicines 2013-2023
1.5.1 Global Pediatric Medicines Market Status and Trend 2013-2023
1.5.2 Regional Pediatric Medicines Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pediatric Medicines 2013-2017
2.2 Sales Market of Pediatric Medicines by Regions
2.2.1 Sales Volume of Pediatric Medicines by Regions
2.2.2 Sales Value of Pediatric Medicines by Regions
2.3 Production Market of Pediatric Medicines by Regions
2.4 Global Market Forecast of Pediatric Medicines 2018-2023
2.4.1 Global Market Forecast of Pediatric Medicines 2018-2023
2.4.2 Market Forecast of Pediatric Medicines by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Pediatric Medicines by Types
3.2 Sales Value of Pediatric Medicines by Types
3.3 Market Forecast of Pediatric Medicines by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Pediatric Medicines by Downstream Industry
4.2 Global Market Forecast of Pediatric Medicines by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Pediatric Medicines Market Status by Countries
5.1.1 North America Pediatric Medicines Sales by Countries (2013-2017)
5.1.2 North America Pediatric Medicines Revenue by Countries (2013-2017)
5.1.3 United States Pediatric Medicines Market Status (2013-2017)
5.1.4 Canada Pediatric Medicines Market Status (2013-2017)
5.1.5 Mexico Pediatric Medicines Market Status (2013-2017)
5.2 North America Pediatric Medicines Market Status by Manufacturers
5.3 North America Pediatric Medicines Market Status by Type (2013-2017)
5.3.1 North America Pediatric Medicines Sales by Type (2013-2017)
5.3.2 North America Pediatric Medicines Revenue by Type (2013-2017)
5.4 North America Pediatric Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Pediatric Medicines Market Status by Countries
6.1.1 Europe Pediatric Medicines Sales by Countries (2013-2017)
6.1.2 Europe Pediatric Medicines Revenue by Countries (2013-2017)
6.1.3 Germany Pediatric Medicines Market Status (2013-2017)
6.1.4 UK Pediatric Medicines Market Status (2013-2017)
6.1.5 France Pediatric Medicines Market Status (2013-2017)
6.1.6 Italy Pediatric Medicines Market Status (2013-2017)
6.1.7 Russia Pediatric Medicines Market Status (2013-2017)
6.1.8 Spain Pediatric Medicines Market Status (2013-2017)
6.1.9 Benelux Pediatric Medicines Market Status (2013-2017)
6.2 Europe Pediatric Medicines Market Status by Manufacturers
6.3 Europe Pediatric Medicines Market Status by Type (2013-2017)
6.3.1 Europe Pediatric Medicines Sales by Type (2013-2017)
6.3.2 Europe Pediatric Medicines Revenue by Type (2013-2017)
6.4 Europe Pediatric Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Pediatric Medicines Market Status by Countries
7.1.1 Asia Pacific Pediatric Medicines Sales by Countries (2013-2017)
7.1.2 Asia Pacific Pediatric Medicines Revenue by Countries (2013-2017)
7.1.3 China Pediatric Medicines Market Status (2013-2017)
7.1.4 Japan Pediatric Medicines Market Status (2013-2017)
7.1.5 India Pediatric Medicines Market Status (2013-2017)
7.1.6 Southeast Asia Pediatric Medicines Market Status (2013-2017)
7.1.7 Australia Pediatric Medicines Market Status (2013-2017)
7.2 Asia Pacific Pediatric Medicines Market Status by Manufacturers
7.3 Asia Pacific Pediatric Medicines Market Status by Type (2013-2017)
7.3.1 Asia Pacific Pediatric Medicines Sales by Type (2013-2017)
7.3.2 Asia Pacific Pediatric Medicines Revenue by Type (2013-2017)
7.4 Asia Pacific Pediatric Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Pediatric Medicines Market Status by Countries
8.1.1 Latin America Pediatric Medicines Sales by Countries (2013-2017)
8.1.2 Latin America Pediatric Medicines Revenue by Countries (2013-2017)
8.1.3 Brazil Pediatric Medicines Market Status (2013-2017)
8.1.4 Argentina Pediatric Medicines Market Status (2013-2017)
8.1.5 Colombia Pediatric Medicines Market Status (2013-2017)
8.2 Latin America Pediatric Medicines Market Status by Manufacturers
8.3 Latin America Pediatric Medicines Market Status by Type (2013-2017)
8.3.1 Latin America Pediatric Medicines Sales by Type (2013-2017)
8.3.2 Latin America Pediatric Medicines Revenue by Type (2013-2017)
8.4 Latin America Pediatric Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Pediatric Medicines Market Status by Countries
9.1.1 Middle East and Africa Pediatric Medicines Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Pediatric Medicines Revenue by Countries (2013-2017)
9.1.3 Middle East Pediatric Medicines Market Status (2013-2017)
9.1.4 Africa Pediatric Medicines Market Status (2013-2017)
9.2 Middle East and Africa Pediatric Medicines Market Status by Manufacturers
9.3 Middle East and Africa Pediatric Medicines Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Pediatric Medicines Sales by Type (2013-2017)
9.3.2 Middle East and Africa Pediatric Medicines Revenue by Type (2013-2017)
9.4 Middle East and Africa Pediatric Medicines Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PEDIATRIC MEDICINES
10.1 Global Economy Situation and Trend Overview
10.2 Pediatric Medicines Downstream Industry Situation and Trend Overview
CHAPTER 11 PEDIATRIC MEDICINES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Pediatric Medicines by Major Manufacturers
11.2 Production Value of Pediatric Medicines by Major Manufacturers
11.3 Basic Information of Pediatric Medicines by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Pediatric Medicines Major Manufacturer
11.3.2 Employees and Revenue Level of Pediatric Medicines Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PEDIATRIC MEDICINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 GSK
12.1.1 Company profile
12.1.2 Representative Pediatric Medicines Product
12.1.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of GSK
12.2 Sanofi
12.2.1 Company profile
12.2.2 Representative Pediatric Medicines Product
12.2.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Sanofi
12.3 Bristol-Myers Squibb
12.3.1 Company profile
12.3.2 Representative Pediatric Medicines Product
12.3.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
12.4 Abbott
12.4.1 Company profile
12.4.2 Representative Pediatric Medicines Product
12.4.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Abbott
12.5 Novartis
12.5.1 Company profile
12.5.2 Representative Pediatric Medicines Product
12.5.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Novartis
12.6 Pfizer
12.6.1 Company profile
12.6.2 Representative Pediatric Medicines Product
12.6.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Pfizer
12.7 Cipla
12.7.1 Company profile
12.7.2 Representative Pediatric Medicines Product
12.7.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Cipla
12.8 Eisai Pharmaceuticals
12.8.1 Company profile
12.8.2 Representative Pediatric Medicines Product
12.8.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Eisai Pharmaceuticals
12.9 Eli Lilly
12.9.1 Company profile
12.9.2 Representative Pediatric Medicines Product
12.9.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Eli Lilly
12.10 F. Hoffman-La Roche
12.10.1 Company profile
12.10.2 Representative Pediatric Medicines Product
12.10.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of F. Hoffman-La Roche
12.11 Glenmark
12.11.1 Company profile
12.11.2 Representative Pediatric Medicines Product
12.11.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Glenmark
12.12 Helsinn Healthcare
12.12.1 Company profile
12.12.2 Representative Pediatric Medicines Product
12.12.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Helsinn Healthcare
12.13 Heron Therapeutics
12.13.1 Company profile
12.13.2 Representative Pediatric Medicines Product
12.13.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Heron Therapeutics
12.14 Ipca Laboratories
12.14.1 Company profile
12.14.2 Representative Pediatric Medicines Product
12.14.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Ipca Laboratories
12.15 Sun Pharmaceutical Industries
12.15.1 Company profile
12.15.2 Representative Pediatric Medicines Product
12.15.3 Pediatric Medicines Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
12.16 Takeda Pharmaceutical
12.17 Lupin Pharmaceuticals
12.18 Merck Sharp & Dohme
12.19 RedHill
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PEDIATRIC MEDICINES
13.1 Industry Chain of Pediatric Medicines
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PEDIATRIC MEDICINES
14.1 Cost Structure Analysis of Pediatric Medicines
14.2 Raw Materials Cost Analysis of Pediatric Medicines
14.3 Labor Cost Analysis of Pediatric Medicines
14.4 Manufacturing Expenses Analysis of Pediatric Medicines
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
